139 related articles for article (PubMed ID: 7531869)
21. Benign prostatic hyperplasia. The Saudi perspective in the year 2000.
Mosli HA; Atwa MA; Mahassini SH
Saudi Med J; 2000 Oct; 21(10):915-20. PubMed ID: 11369951
[TBL] [Abstract][Full Text] [Related]
22. The role of combination medical therapy in benign prostatic hyperplasia.
Greco KA; McVary KT
Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
[TBL] [Abstract][Full Text] [Related]
23. Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications.
Seftel A; Rosen R; Kuritzky L
Int J Impot Res; 2007; 19(4):386-92. PubMed ID: 17377613
[TBL] [Abstract][Full Text] [Related]
24. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
Miner M; Rosenberg MT; Perelman MA
Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
[TBL] [Abstract][Full Text] [Related]
25. The natural history of benign prostatic hyperplasia.
Fitzpatrick JM
BJU Int; 2006 Apr; 97 Suppl 2():3-6; discussion 21-2. PubMed ID: 16507045
[TBL] [Abstract][Full Text] [Related]
26. Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waiting.
Mochtar CA; Kiemeney LA; Laguna MP; van Riemsdijk MM; Barnett GS; Debruyne FM; de la Rosette JJ
Urology; 2005 Feb; 65(2):300-5. PubMed ID: 15708042
[TBL] [Abstract][Full Text] [Related]
27. [Prostate cancer after prostatectomy for benign prostatic hyperplasia].
Hua L; Zhang J; Wu H; Sui Y; Zhang W; Qian L; Wang Z
Zhonghua Nan Ke Xue; 2004 Aug; 10(8):612-3. PubMed ID: 15362527
[TBL] [Abstract][Full Text] [Related]
28. An economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.
McDonald H; Hux M; Brisson M; Bernard L; Nickel JC
Can J Urol; 2004 Aug; 11(4):2327-40. PubMed ID: 15380054
[TBL] [Abstract][Full Text] [Related]
29. Is transurethral microwave thermotherapy an alternative to medical therapy for patients with benign prostatic hyperplasia?
Djavan B
Tech Urol; 2000 Dec; 6(4):300-6. PubMed ID: 11108570
[TBL] [Abstract][Full Text] [Related]
30. Watchful waiting in benign prostatic hyperplasia.
Wiygul J; Babayan RK
Curr Opin Urol; 2009 Jan; 19(1):3-6. PubMed ID: 19057209
[TBL] [Abstract][Full Text] [Related]
31. The impact of 5-alpha-reductase inhibitors on the number of prostatectomies for benign prostatic hyperplasia.
Agha AH; Roy JB; Culkin DJ; Lyon K
Adv Ther; 1995; 12(6):361-6. PubMed ID: 10163332
[TBL] [Abstract][Full Text] [Related]
32. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
[TBL] [Abstract][Full Text] [Related]
33. Definition of at-risk patients: dynamic variables.
Emberton M
BJU Int; 2006 Apr; 97 Suppl 2():12-5; discussion 21-2. PubMed ID: 16507047
[TBL] [Abstract][Full Text] [Related]
34. What will replace TURP?
Brawer MK; McConnell JD; Oesterling JE
Contemp Urol; 1992 Feb; 4(2):30-40. PubMed ID: 10151029
[TBL] [Abstract][Full Text] [Related]
35. Treatment of benign prostatic hyperplasia: surgery, medical therapy, or watchful waiting.
Sall M; Bruskewitz RC
Compr Ther; 1996 Sep; 22(9):554-8. PubMed ID: 8902346
[No Abstract] [Full Text] [Related]
36. [Who works in the prevention and early detection of benign prostatic hyperplasia and prostate cancer in Croatia?].
Kranjcević K; Marković BB
Acta Med Croatica; 2007 Feb; 61(1):45-8. PubMed ID: 17593640
[TBL] [Abstract][Full Text] [Related]
37. BPH: costs and treatment outcomes.
Nickel JC
Am J Manag Care; 2006 Apr; 12(5 Suppl):S141-8. PubMed ID: 16613528
[TBL] [Abstract][Full Text] [Related]
38. Finasteride in the treatment of patients with moderate symptoms of benign prostatic hyperplasia.
Magoha GA
East Afr Med J; 1998 May; 75(5):260-3. PubMed ID: 9746993
[TBL] [Abstract][Full Text] [Related]
39. Treatment and pharmacologic management of BPH in the context of common comorbidities.
O'Leary MP
Am J Manag Care; 2006 Apr; 12(5 Suppl):S129-40. PubMed ID: 16613527
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of benign prostatic hypertrophy].
Romics I
Orv Hetil; 2003 Nov; 144(45):2229-30. PubMed ID: 14686009
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
